IL17A and leukemia: Aside from the known immunosuppressive mechanisms of AML [9–13], we identified a novel process induced by leukemic cells via soluble factors through which Th17 are converted into IL-17/IL-10-secreting cells, creating an environment with reduced immune control and thus probably favoring leukemia immune escape.